Practice Management
A new epinephrine nasal spray has been approved by the Food and Drug Administration (FDA) for the treatment of allergic reactions, including anaphylaxis, in adult and pediatric patients who weight at least 66 pounds, according to an FDA press release. Until now, epinephrine has only been available for patients as an injection or auto-injection device. The agency says the new delivery mechanism addresses an unmet need in that some people who need urgent epinephrine treatment …
Read More
Click Here to download the article PDF Ivan Koay MBChB, MRCS, FRNZCUC, MD Immersive Virtual Reality Use in Reducing Pediatric Procedural Anxiety Take-home point: Immersive virtual reality (IVR) use in pediatric patients significantly improved pain and anxiety compared with the control group. Citation: Wong C, Choi K. Effects of an immersive virtual reality intervention on pain and anxiety among pediatric patients undergoing venipuncture: a randomized clinical trial. JAMA Netw Open. 2023;6(2):e230001. Relevance: Poorly managed procedural …
Read More